Telmisartan/Amlodipine
Sponsors
Boehringer Ingelheim, Jeil Pharmaceutical Co., Ltd., IlDong Pharmaceutical Co Ltd
Conditions
Essential HypertensionHealthyHyperlipidemiaHypertensionHypertension With Hyperlipidemia
Phase 1
Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers
CompletedNCT02183675
Start: 2014-07-31End: 2014-10-31Updated: 2016-11-30
Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Male and Female Volunteers
CompletedNCT02259777
Start: 2007-09-30Updated: 2014-10-09
Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers
CompletedNCT02259829
Start: 2007-09-30Updated: 2014-10-09
The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine
CompletedNCT02387619
Start: 2015-02-28End: 2015-07-31Updated: 2016-06-24
Phase 3
TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch
CompletedNCT01134393
Start: 2010-05-31Updated: 2014-01-15
Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension Patients
CompletedNCT02738632
Start: 2015-05-31End: 2016-08-31Target: 300Updated: 2016-11-25
Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia
CompletedNCT03566316
Start: 2015-11-24End: 2017-06-16Updated: 2018-06-25